GlobeNewswire

NKGen Biotech to Present on Potential of Troculeucel in Neurodegenerative Diseases at Biologics Manufacturing Korea 2026
10/09/2026
SANTA ANA, Calif., Sept. 10, 2026 (GLOBE NEWSWIRE) -- NKGen Biotech, Inc. (OTC: NKGN) (“NKGen” or the “Company”), a clinical-stage biotechnology company focused on the development and commercialization of innovative [...]
Alignment Health’s Fifth Annual Survey Finds Seniors Falling Further Behind: Aging in Place Challenges Continue to Rise as Support Gaps Widen
10/09/2026
Key indicators worsened in 2026, including aging in place challenges, support gaps, and medical debt ORANGE, Calif., Sept. 10, 2026 (GLOBE NEWSWIRE) -- Ninety percent of seniors report at least one factor affecting [...]
Nanox Expands Latin American Presence with Nanox.ARC Distribution Agreement in Costa Rica
10/09/2026
Agreement with SOLME RC, SA Marks the third Latin American market this year PETACH TIKVA, Israel, Sept. 10, 2026 (GLOBE NEWSWIRE) -- Nanox Imaging Ltd. (NASDAQ: NNOX) ("Nanox"), a leader in innovative medical imaging [...]
Aprea Therapeutics to Present at H.C. Wainwright 28th Annual Global Investment Conference
10/09/2026
DOYLESTOWN, Pa., Sept. 10, 2026 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (Nasdaq: APRE) (“Aprea”, or the “Company”), a clinical-stage precision medicine oncology company focused on the discovery and development of [...]
SCYNEXIS Announces Appointment of Sanjay Subramanian as Chief Financial Officer
10/09/2026
Accomplished biopharmaceutical finance executive brings extensive experience driving capital markets activities, strategic transactions, and growth across public companies JERSEY CITY, N.J., Sept. 10, 2026 (GLOBE [...]
Starton Therapeutics to Present at MedInvest Biotech & Pharma Conference
10/09/2026
PARAMUS, N.J., Sept. 10, 2026 (GLOBE NEWSWIRE) -- Starton Therapeutics Inc . (“Starton”), a clinical-stage biotechnology company employing standard-of-care therapies with proprietary delivery technologies, today [...]
ORYZON to Participate in Upcoming Events in September and October
10/09/2026
MADRID and CAMBRIDGE, Mass., Sept. 10, 2026 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company and global leader in epigenetics, announced today that its [...]
Adagene Announces that Third Arc Bio Has Selected First Lead Candidate under Amended Strategic Collaboration for Development of Masked CD3 T Cell Engagers Utilizing SAFEbody® Technology
10/09/2026
Amended terms of agreement include a transition to an integrated asset and technology partnership. SAN DIEGO and SUZHOU, China, Sept. 10, 2026 (GLOBE NEWSWIRE) -- Adagene Inc. (“Adagene”) (Nasdaq: ADAG), a platform- [...]
BGI Group Showcases New Technologies for Advancing Personalized Health at 2026 Global New Product Launch Event
10/09/2026
SHENZHEN, China, Sept. 10, 2026 (GLOBE NEWSWIRE) -- On September 9, BGI Group held its 2026 Global New Product Launch Event at BGI Center in Shenzhen, marking the organization’s 27th anniversary. Under the theme “ [...]
Galectin Therapeutics to Present at the H.C. Wainwright 28th Annual Global Investment Conference
10/09/2026
NORCROSS, Ga., Sept. 10, 2026 (GLOBE NEWSWIRE) -- Galectin Therapeutics, Inc. (NASDAQ: GALT), the leading developer of therapeutics that target galectin proteins, today announced that company management will present and [...]
IN8bio to Present at H.C. Wainwright 28th Annual Global Investment Conference
10/09/2026
NEW YORK, Sept. 10, 2026 (GLOBE NEWSWIRE) -- IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical company developing innovative gamma-delta (γδ) T cell therapies and T cell engagers for cancer and autoimmune [...]
Biora Therapeutics to Initiate First Human Trial of BioJet™ Oral Biologic Delivery Capsule
10/09/2026
Healthy volunteer study will evaluate ingestible delivery capsule for oral, needle-free administration of adalimumab with topline data expected by early 2027 SAN DIEGO, Sept. 10, 2026 (GLOBE NEWSWIRE) -- Biora [...]
IMUNON Enters Cooperative Research and Development Agreement with National Cancer Institute to Advance Clinical Development of IMNN-001
10/09/2026
Collaboration with NCI's Cancer Therapy Evaluation Program (CTEP) will evaluate IMNN-001 in new indications and combination regimens IMUNON retains ownership of its background intellectual property with an opportunity [...]
Outlook Therapeutics CEO, Bob Jahr, Discusses FDA Approval and Commercial Opportunity for LYTENAVA™ in Virtual Investor CEO Connect Segment
10/09/2026
Access the segment here ISELIN, N.J., Sept. 10, 2026 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on the development and commercialization of LYTENAVA™ (bevacizumab- [...]
Canada Steps Up to Support Global Cancer Care with First Contribution to IAEA’s Rays of Hope Initiative
10/09/2026
TORONTO, Sept. 10, 2026 (GLOBE NEWSWIRE) -- The Canadian Nuclear Isotope Council (CNIC) today announced Canada’s first official contribution to the International Atomic Energy Agency’s (IAEA) Rays of Hope initiative, a [...]
UPDATE -- Starton Therapeutics to Present at MedInvest Biotech & Pharma Conference
10/09/2026
PARAMUS, N.J., Sept. 10, 2026 (GLOBE NEWSWIRE) -- Starton Therapeutics Inc . (“Starton”), a clinical-stage biotechnology company employing standard-of-care therapies with proprietary delivery technologies, today [...]
Interra Health Adds Support for New GLP-1 Bridge Program, Helping Seniors on Medicare Access Weight-Loss Medications
10/09/2026
Within just two months, the program has reached 30,000+ prescribers and delivered 170,000+ point-of-prescribe alerts, helping Medicare patients access GLP-1 medication for obesity for just $50/month BOSTON, Sept. 10, [...]
Bionano Laboratories Announces Proposed Local Coverage Determination (LCD) from MolDX for Genome-Wide Detection of Structural Variants in Hematologic Neoplasms
10/09/2026
SAN DIEGO, Sept. 10, 2026 (GLOBE NEWSWIRE) -- Bionano Laboratories, a wholly-owned subsidiary of Bionano Genomics, Inc. (Nasdaq: BNGO) that offers CLIA-certified laboratory developed test (LDTs), today announced that [...]
Vanquish Brands Partners with Select BC Craft Growers to Bring Premium Cannabis to Markets Across Canada Via the Pistol and Paris Brand
10/09/2026
AGASSIZ, British Columbia, Sept. 10, 2026 (GLOBE NEWSWIRE) -- Vanquish Holdings Inc. (“Vanquish”), operating under the Vanquish Brands name, is a Canadian cannabis house-built Legacy to Legal™, combining the standards, [...]

Pages

Other news

Test 2

Lorem ipsum

Test 1

Lorem upsum